SCHEMBL20230680

SCHEMBL20230680

CC1(C)c2ccccc2N(c2ccccc2)c2cc(-c3ccc4c(c3)C(C)(C)c3cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc3N4c3ccccc3)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
MAPT P10636 5/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 2/20 0.35
L3MBTL1 Q9Y468 3/20 0.33
ADAMTS5 Q9UNA0 1/20 0.33
NTSR1 P30989 2/20 0.33
LMNA P02545 4/20 0.32
MAPK1 P28482 3/20 0.32
KDM4E B2RXH2 2/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GLA P06280 1/20 0.32
PGR P06401 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20230674 0.96 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20230653 0.95 MEN1 (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20230654 0.95 MEN1 (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL12436276 0.95 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20230688 0.94 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13833106 0.94 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13833099 0.94 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17278581 0.94 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13833109 0.94 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13833111 0.93 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNT1 MEN1 666/4885KMT2A 1608/4885MAPT 1926/4885
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CCNT1 MEN1 666/4885KMT2A 1608/4885MAPT 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.